melagatran,
N-((R)-(((2S)-2-((-p-amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine,
Melagatran,
159776-70-2,
UNII-2A9QP32MD4,
Melagatran [INN],
2A9QP32MD4,
CHEBI:43966,
MELAGATRAN (ASTRA-ZENECA),
C22H31N5O4,
Melagatran (INN),
N-((R)-(((2S)-2-((-p-Amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine,
[((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID,
MEL,
H-319/68,
N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine,
2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid,
Glycine, N-((1R)-2-((2S)-2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-,
Glycine, N-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (S-(R*,S*))-,
N-[(1R)-2-{(2S)-2-[(4-carbamimidoylbenzyl)carbamoyl]azetidin-1-yl}-1-cyclohexyl-2-oxoethyl]glycine,
Melagatran AstraZeneca,
AC1L4DN8,
SCHEMBL27652,
CHEMBL266349,
GTPL6382,
BDBM29388,
CTK8F0798,
DTXSID30166724,
1k22,
ZINC3809827,
AKOS022181213,
AJ-45669,
LS-72219,
SC-51122,
RT-013681,
C21551,
D07143,
208555-EP2374780A1,
208555-EP2374781A1,
H-319-68,
J-009643,
2-(((R)-2-((S)-2-((4-Carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)acetic acid,
N-[(1R)-2-[(2S)-2-[[[[4-(Aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]glycine,
Exanta,
Melagatran D11,
D01MUU,
CID183797,
C22-H31-N5-O4,
CS-T-31715,
C109573,
N-[(R)-[[(2S)-2-[[p-amidinobenzyl]carbamoyl]-1-azetidinyl]carbonyl]cyclohexylmethyl]glycine,